Keywords: kv, beijing, med-pharm, chinese, clindesse, deal, usa-based
KV and Beijing Med-Pharm in Chinese Clindesse deal
Article | 23 July 2007
USA-based drugmaker KV Pharmaceutical has entered into an agreement with China's Beijing Med-Pharm for exclusive Chinese marketing and distribution rights ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
